– THC BioMed Intl Ltd. (“THC BioMed” or the “Company“) is pleased to announce that its fulfillment team will today ship a second shipment of THC Kiss Cannabis Beverage to British Columbia Liquor Distribution Branch. The fulfillment team will also complete our first shipment to our new Saskatchewan distributor, National Cannabis Distribution. This shipment will be comprised of dried cannabis and our ready-to-drink cannabis beverage shot, “THC Kiss.”
“We are scaling supply and increasing our footprint in the beverage space,” commented John Miller, President and CEO of THC BioMed. “Our initial feedback from consumers has been very encouraging and all of our efforts will now be focused on dominating this high margin sector. We are proud to have developed a true alternative to smoking cannabis.”
THC has filed applications for three Canadian trademarks. The proposed design trademarks are the “THC KISS” logo, “THC Plant Science” with the logo and “THC Kiss THC BioMed Plant Science” with the logo. The logo is the swooping leaf logo used by THC for many years.
The application will be reviewed and the Company will be notified if there are any objections.
THC BioMed is a Cannabis Act Licensed Producer of medical and recreational cannabis. It is licensed to cultivate and sell dried, extract, edible and topical cannabis. The Company is on the leading edge of scientific research and the development of products and services related in the medical cannabis industry. Management believes THC BioMed is well-positioned to be in the forefront of this rapidly growing industry.
This press release may include forward-looking information within the meaning of Canadian securities legislation, concerning the business of THC BioMed. Forward-looking information is based on certain key expectations and assumptions made by the management of THC BioMed. In some cases, you can identify forward-looking statements by the use of words such as “will,” “aims,” “may,” “would,” “expect,” “intend,” “plan,” “seek,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” “continue,” “likely,” “could” and variations of these terms and similar expressions, or the negative of these terms or similar expressions. Forward-looking statements in this release are made as of the date of this press release and include that (a) the second shipment to B.C. will be completed on the date of this release, (b) the shipment to Saskatchewan will be completed, (c) all of THC’s efforts will now be focused on dominating this high margin sector, and (d) THC BioMed will be on the forefront of this rapidly growing industry. Although THC BioMed believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because THC BioMed can give no assurance that they will prove to be correct. THC disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.
The Canadian Securities Exchange (CSE) has not reviewed and does not accept responsibility for the adequacy or the accuracy of the contents of this release.
All posts made on this website are provided for information purposes only. None of the information here is intended as investment advice, as an offer or solicitation of an offer to buy or sell, or as a recommendation, endorsement, or sponsorship of any security, Company, or fund. Before making an investment decision, you should seek the advice of a qualified and registered securities professional. Candlr is not receiving payment or commissions from companies for shared content on Candlr website unless its specified. View full disclaimer HERE.